EE426 A Comparison of the Cost-Saving Impact of Biosimilar Switching Policies across Canadian Provinces: A Case-Study for a Ranibizumab Biosimilar
| Autor: | Keady, S., Goyert-Stephens, N., Xin, Q., Morris, L., Thomas, M., Foxon, G. |
|---|---|
| Zdroj: | In Value in Health June 2023 26(6) Supplement:S137-S137 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect